REFERENCIAS

American Diabetes Association: Aspirin therapy in diabetes (Position Statement). Diabetes Care 24 (Suppl. 1):S62–S63, 2001

American Diabetes Association: Care of children with diabetes in the school and day care setting (Position Statement). Diabetes Care 24 (Suppl. 1):S108–S112, 2001

American Diabetes Association: Diabetic nephropathy (Position Statement). Diabetes Care 24 (Suppl. 1):S69–S72, 2001

American Diabetes Association: Diabetic retinopathy (Position Statement). Diabetes Care 24 (Suppl. 1):S73–S76, 2001

American Diabetes Association: Gestational diabetes mellitus (Position Statement). Diabetes Care 24 (Suppl. 1):S77–S79, 2001

American Diabetes Association: Implications of the United Kingdom Prospective Diabetes Study (Position Statement). Diabetes Care 24 (Suppl. 1):S28–S32, 2001

American Diabetes Association: Management of dyslipidemia in adults with diabetes (Position Statement). Diabetes Care 24 (Suppl. 1):S58–S61, 2001

American Diabetes Association: Management of hyperglycemic crisis (Position Statement). Diabetes Care 24 (Suppl. 1):S83–S90, 2001

American Diabetes Association: Nutrition recommendations and principles for people with diabetes mellitus (Position Statement). Diabetes Care 24 (Suppl. 1):S44–S47, 2001

American Diabetes Association: Preconception care of women with diabetes (Position Statement). Diabetes Care 24 (Suppl. 1):S66–S68, 2001

American Diabetes Association: Preventive foot care in people with diabetes (Position Statement). Diabetes Care 24 (Suppl. 1):S56–S57, 2001

American Diabetes Association: Smoking and diabetes (Position Statement). Diabetes Care 24 (Suppl. 1):S64–S65, 2001

American Diabetes Association: Type 2 diabetes in children and adolescents (Consensus Statement). Diabetes Care 23:381–389, 2000

American Diabetes Association: Diagnosis of coronary heart disease in people with diabetes (Consensus Statement). Diabetes Care 21:1551–1559, 1998

American Diabetes Association: Treatment of hypertension in diabetes (Consensus Statement). Diabetes Care 16:1394–1401, 1993

Andersson DKG, Svardsudd K: Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 18:1534–1543, 1995

Cryer PE, Fisher JN, Shamoon H: Hypoglycemia (Technical Review). Diabetes Care 17:734–755, 1994

Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977–986, 1993

Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 24 (Suppl. 1):S5–S20, 2001

Expert Panel on Blood Cholesterol Levels in Children and Adolescents: Treatment recommendations of the National Cholesterol Education Program Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 89 (Suppl.):525–584, 1992

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 269:3015–3023, 1993

Hansson L, Zanchett A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood-pressure lowering and low-dose aspirin on patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351:1755–1762, 1998

Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). Bethesda, MD, National Institutes of Health, National Heart, Lung and Blood Institute, 1997 (NIH publ. no. 98-4080)

Kasiske BL, Kalikl RSN, Ma JZ: Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med 118:129–138, 1993

Moss SE, Klein R, Klein BEK, Meuer MS: The association of glycemia and cause-specific mortality in a diabetic population. Arch Int Med 154:2473–2479, 1994

Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyosyi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non­insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103–117, 1995

Skyler JS (Ed.): Medical Management of Type 1 Diabetes. 3rd ed. Alexandria, VA, American Diabetes Association, 1998

UK Prospective Diabetes Study Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837–853, 1998

UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 317:703–713, 1998

Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K: Ten year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non­insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36:1174–1184, 1993

Weir GC, Nathan DM, Singer DE: Standards of care for diabetes (Technical Review). Diabetes Care 17:1514–1522, 1994

Zimmerman BR (Ed.): Medical Management of Type 2 Diabetes. 4th ed. Alexandria, VA, American Diabetes Association, 1998